IL18 and gastric cancer: IL-18 promotes the immune escape of gastric cancer cells by upregulating programmed cell death 1 (PD1) in NK cells, downregulating CD70 in tumor cells and inhibiting the CASP8-mediated apoptosis in gastric cancer cells [119,120,121].